Year |
Citation |
Score |
2020 |
Blackburn JK, Curry DW, Thomsen AN, Roth RH, Elsworth JD. Pioglitazone activates paraoxonase-2 in the brain: A novel neuroprotective mechanism. Experimental Neurology. 113234. PMID 32044330 DOI: 10.1016/J.Expneurol.2020.113234 |
0.509 |
|
2019 |
Curry DW, Berro LF, Belkoff AR, Sulima A, Rice KC, Howell LL. Sensitization to the prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA). Neuropharmacology. PMID 30922893 DOI: 10.1016/J.Neuropharm.2019.03.017 |
0.544 |
|
2019 |
Stutz B, Nasrallah C, Nigro M, Curry D, Liu ZW, Gao XB, Elsworth JD, Mintz L, Horvath TL. Dopamine neuronal protection in the mouse Substantia nigra by GHSR is independent of electric activity. Molecular Metabolism. PMID 30833218 DOI: 10.1016/J.Molmet.2019.02.005 |
0.607 |
|
2018 |
Curry DW, Stutz B, Andrews ZB, Elsworth JD. Targeting AMPK Signaling as a Neuroprotective Strategy in Parkinson's Disease. Journal of Parkinson's Disease. PMID 29614701 DOI: 10.3233/Jpd-171296 |
0.629 |
|
2017 |
Pitts EG, Curry DW, Hampshire KN, Young MB, Howell LL. (±)-MDMA and its enantiomers: potential therapeutic advantages of R(-)-MDMA. Psychopharmacology. PMID 29248945 DOI: 10.1007/S00213-017-4812-5 |
0.625 |
|
2017 |
Curry DW, Young MB, Tran AN, Daoud GE, Howell LL. Separating the agony from ecstasy: R(-)-3,4 methylenedioxymethamphetamine has prosocial and therapeutic-like effects without signs of neurotoxicity in mice. Neuropharmacology. PMID 28993129 DOI: 10.1016/J.Neuropharm.2017.10.003 |
0.646 |
|
2017 |
Curry D, Belkoff A, Howell L. Prosocial effects and neurotoxicity of (−)-3,4-methylenedioxymethamphetamine in mice Drug and Alcohol Dependence. 171: e50. DOI: 10.1016/J.Drugalcdep.2016.08.149 |
0.486 |
|
2012 |
Morrison KE, Curry DW, Cooper MA. Social status alters defeat-induced neural activation in Syrian hamsters. Neuroscience. 210: 168-78. PMID 22433296 DOI: 10.1016/J.Neuroscience.2012.03.002 |
0.462 |
|
Show low-probability matches. |